日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of a novel (177)Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

对一种新型的（177）Lu标记的治疗性Affibody分子进行评估，该分子具有去免疫化的ABD结构域和改进的生物分布特征。

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06840-5
Liu, Yongsheng; Oroujeni, Maryam; Liao, Yunqi; Vorobyeva, Anzhelika; Bodenko, Vitalina; Orlova, Anna; Konijnenberg, Mark; Carlqvist, Matilda; Wahlberg, Elisabet; Loftenius, Annika; Frejd, Fredrik Y; Tolmachev, Vladimir
免疫/内分泌
发表日期：2024
文献求助 收藏

Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy

利用Affibody PET成像技术检测HER2表达阳性癌症是指导HER2靶向治疗的关键

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines12051088
Eissler, Nina; Altena, Renske; Alhuseinalkhudhur, Ali; Bragina, Olga; Feldwisch, Joachim; Wuerth, Guido; Loftenius, Annika; Brun, Nikolai; Axelsson, Rimma; Tolmachev, Vladimir; Sörensen, Jens; Frejd, Fredrik Y
肿瘤
肿瘤免疫
HER2
发表日期：2024
文献求助 收藏

Phase I clinical evaluation of (99m)Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer

99mTc标记的Affibody分子用于乳腺癌HER2表达成像的I期临床评估

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.86770
Bragina, Olga; Chernov, Vladimir; Larkina, Mariia; Rybina, Anstasiya; Zelchan, Roman; Garbukov, Eugeniy; Oroujeni, Maryam; Loftenius, Annika; Orlova, Anna; Sörensen, Jens; Frejd, Fredrik Y; Tolmachev, Vladimir
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule (188)Re-ZHER2:41071

利用第二代HER2靶向Affibody分子(188)Re-ZHER2:41071对表达HER2的异种移植瘤进行实验性治疗

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics14051092
Liu, Yongsheng; Vorobyeva, Anzhelika; Orlova, Anna; Konijnenberg, Mark W; Xu, Tianqi; Bragina, Olga; Loftenius, Annika; Rosander, Erica; Frejd, Fredrik Y; Tolmachev, Vladimir
HER2
发表日期：2022
文献求助 收藏

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain

HER2 靶向 ABD 融合 Affibody® 分子 177Lu-ABY-271 和 177Lu-ABY-027 的比较临床前评估：DOTA 位置对 ABD 域的影响

期刊:Pharmaceutics
影响因子:4.9
doi:10.3390/pharmaceutics13060839
Yongsheng Liu, Anzhelika Vorobyeva, Tianqi Xu, Anna Orlova, Annika Loftenius, Theresa Bengtsson, Per Jonasson, Vladimir Tolmachev, Fredrik Y Frejd
HER2
发表日期：2021
文献求助 收藏

In vitro effects of mercuric chloride (HgCl2) on human mononuclear cells

氯化汞（HgCl2）对人单核细胞的体外作用

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1046/j.1365-2249.1997.4531470.x
Loftenius, A; Ekstrand, J; Möller, E
细胞生物学
单核细胞
发表日期：1997
文献求助 收藏